US EditionStem cell therapy shows promise for treating advanced Parkinson's disease
- Two early-stage clinical trials, published in *Nature* on April 16, tested stem cell therapies for Parkinson's disease.
- Parkinson's is a neurodegenerative disease where cells producing dopamine die, leading to movement and other issues.
- Researchers transplanted stem cell-derived cells into patients' brains in Japan, the U.S., and Canada.
- Jun Takahashi stated, "The main conclusion is that we confirmed the safety."
- The trials suggest stem cell therapies are safe and show some promise, though more research is necessary.
38 Articles
38 Articles
New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects.The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, tremors and movement — for a longer period of time for patients who were also taking at least 400 mg of levodopa a day and were experiencing "motor fluctuations," which are periods of time when the medication wears off and symptoms return, according…
Stem cell therapy shows promise for treating advanced Parkinson's disease
A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical trial reported in Nature.
Coverage Details
Bias Distribution
- 53% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
